Tamás Révész - Concepedia

Author

Tamás Révész

Also Known As

Revesz Tamas, Revesz, Tamas, Sarah Purdy, T Revesz, T Révész, T. Revesz, T. RÉVÉSZ, T. Révész, Tamas Revesz, Tamas Révész

110

Publications

1.7K

Citations

H-Index

Concepts

All Affiliations

Women's and Children's Hospital The University of Adelaide UNSW Sydney South Australia Pathology Children's Cancer Institute Australia

About

Tamás Révész is an author at Women's and Children's Hospital specializing in medicine, hematology, and pediatrics.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	15	19	865
2	Health Sciences	7	7	480
3	Cell Biology	2	2	26
4	Blood Transplantation	1	1	61
5	Emergency Medicine	1	1	20

Tamás Révész

Publications

1.5K

Citations

H-Index

Page 1

	Year	Citations
Effect of mitoxantrone on outcome of children with first relapse of acute lymphoblastic leukaemia (ALL R3): an open-label randomised trial Catriona Parker, Rachel Waters, Carly Leighton, The Lancet Hematological MalignancyLymphoid NeoplasiaAcute Lymphoblastic LeukaemiaPediatric HematologyMedicine	2010	331
Integration of genetic and clinical risk factors improves prognostication in relapsed childhood B-cell precursor acute lymphoblastic leukemia Julie Irving, Amir Enshaei, Catriona Parker, Blood	2016	133
Persistent <scp>MRD</scp> before and after allogeneic <scp>BMT</scp> predicts relapse in children with acute lymphoblastic leukaemia Rosemary Sutton, Peter J. Shaw, Nicola C. Venn, British Journal of Haematology	2014	74
Outcome of Central Nervous System Relapses In Childhood Acute Lymphoblastic Leukaemia – Prospective Open Cohort Analyses of the ALLR3 Trial Ashish Masurekar, Catriona Parker, Milensu Shanyinde, PLoS ONE	2014	61
High-risk childhood acute lymphoblastic leukemia in first remission treated with novel intensive chemotherapy and allogeneic transplantation Glenn M. Marshall, Luciano Dalla Pozza, Rosemary Sutton, Leukemia Hematological MalignancyOncologyMarrow TransplantationTransplantationFirst Remission	2013	61
Risk factors and outcomes in children with high-risk B-cell precursor and T-cell relapsed acute lymphoblastic leukaemia: combined analysis of ALLR3 and ALL-REZ BFM 2002 clinical trials Cornelia Eckert, Catriona Parker, Anthony V. Moorman, European Journal of Cancer	2021	61
Preemptive alloimmune intervention in high-risk pediatric acute lymphoblastic leukemia patients guided by minimal residual disease level before stem cell transplantation Arjan C. Lankester, Marc Bierings, Elisabeth R. van Wering, Leukemia TransplantationMarrow TransplantationBone Marrow FailurePediatric HematologyStem Cell Transplantation	2010	60
The adverse effect of prolonged prednisolone pretreatment in children with acute lymphoblastic leukemia Tamás Révész, Gabriella Kardos, P. Kajtár, Cancer Hematological MalignancyRheumatologyContinuous Complete RemissionOncologyPediatric Hematology	1985	60
New cellular markers at diagnosis are associated with isolated central nervous system relapse in paediatric B‐cell precursor acute lymphoblastic leukaemia Vincent H. J. van der Velden, Daphne de Launaij, Jeltje F. de Vries, British Journal of Haematology	2015	57
Relapses and treatment-related events contributed equally to poor prognosis in children with ABL-class fusion positive B-cell acute lymphoblastic leukemia treated according to AIEOP-BFM protocols Gunnar Cario, Veronica Leoni, Valentino Conter, Haematologica	2019	56

Page 1